Gründungsjahr:
2002
Mitarbeiter:
51-500
Firmenseite:
Zur Website
Expansion:
national
The Institute of Molecular Medicine and Experimental Immunology (IMMEI) was founded in 2002.It is situated on the medical Campus of the Friedrich-Wilhelms-Universitat Bonn. The scientific mission of IMMEI is to understand the molecular and cellular mechanisms controlling the immune response in a local fashion to develop either into immunity or immune tolerance. Comprehensive knowledge of the physiological regulation of immune tolerance is required to understand the immuno-pathology of chronic inflammation after infection, autoimmunity and perhaps even failure of the immune response to eliminate tumors. Research groups at IMMEI also join forces to develop novel methods to modulate cell function within tissue using laser-assisted nanoparticle-mediated strategies. Ultimately, we intend to develop new strategies to modulate local immune responses for therapeutic purposes.